Publications by authors named "Reinaldo Acevedo"

Claim this Profile
D
Drug delivery systems incorporating bile salts: advancements since the conception of bilosomes.
Mohammad A Obeid, Marta Ruano-Aldea, Reinaldo Acevedo, Virgil Schjins, Manal M Alsaadi

Ther Deliv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Antibodies in the Treatment of SARS-CoV-2 Virus Infection, and Evaluating Their Contribution to Antibody-Dependent Enhancement of Infection.
Mohammed A H Farouq, Reinaldo Acevedo, Valerie A Ferro, Paul A Mulheran, Mohammed M Al Qaraghuli

Int J Mol Sci· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal and systemic immune responses following mucosal immunisation of tetanus toxoid entrapped in lipid nanoparticles prepared by microwave reactor.
Ayman Gebril, Mohammad A Obeid, Ewan M Bennett, Anairis Pujol, Mario L Chovel, Reinaldo Acevedo

Eur J Pharm Biopharm· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes.
Nya L Fraleigh, Reynaldo Oliva, Jordan D Lewicky, Alexandrine L Martel, Reinaldo Acevedo

PLoS One· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeat-Dose Toxicity Study Using the AFPL1-Conjugate Nicotine Vaccine in Male Sprague Dawley Rats.
Reynaldo Oliva, Nya L Fraleigh, Jordan D Lewicky, Mildrey Fariñas, Tamara Hernández, Reinaldo Acevedo

Pharmaceutics· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal Antibodies Against the Capsular Polysaccharides A, C, Y, W, and X of Neisseria meningitidis: A Platform for the Quality Control of Meningococcal Vaccines.
Elizabeth González, Fátima Reyes, Oscar Otero, Frank Camacho, Maribel Cuello, Reinaldo Acevedo

Methods Mol Biol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations.
Reinaldo Acevedo, Xilian Bai, Ray Borrow, Dominique A Caugant, Josefina Carlos

Expert Rev Vaccines· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outer membrane vesicles extracted from Neisseria meningitidis serogroup X for prevention of meningococcal disease in Africa.
Reinaldo Acevedo, Caridad Zayas, Gunnstein Norheim, Sonsire Fernández, Barbara Cedré

Pharmacol Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the Adjuvant Finlay Proteoliposome (AFPL1).
Nya L Fraleigh, Justin Boudreau, Nitin Bhardwaj, Nelson F Eng, Yanal Murad, Reinaldo Acevedo

Heliyon· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacterial outer membrane vesicles and vaccine applications.
Reinaldo Acevedo, Sonsire Fernández, Caridad Zayas, Armando Acosta, Maria Elena Sarmiento

Front Immunol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second international congress on immunopharmacology: delivery systems and current strategies for drug design.
Reinaldo Acevedo, Mario Landys, Armando Acosta, Herve Bercovier, Mohd Nor Norazmi

BMC Immunol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune adjuvant effect of V. cholerae O1 derived Proteoliposome coadministered by intranasal route with Vi polysaccharide from Salmonella Typhi.
Reinaldo Acevedo, Adriana Callicó, Yisabel Aranguren, Caridad Zayas, Yolanda Valdés

BMC Immunol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup B.
Caridad Zayas, Domingo González, Reinaldo Acevedo, Judith del Campo, Miriam Lastre

BMC Immunol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cochleates derived from Vibrio cholerae O1 proteoliposomes: the impact of structure transformation on mucosal immunisation.
Reinaldo Acevedo, Oliver Pérez, Caridad Zayas, José L Pérez, Adriana Callicó

PLoS One· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing efficacy of mucosal vaccines.
Ayman Gebril, Manal Alsaadi, Reinaldo Acevedo, Alexander B Mullen, Valerie A Ferro

Expert Rev Vaccines· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AFCo1 as nasal adjuvant of capsular polysaccharide from Neisseria meningitidis serogroup C induces systemic and mucosal immune responses.
Belkis Romeu, Elizabeth González, Caridad Zayas, Judith Del Campo, Reinaldo Acevedo

Scand J Infect Dis· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses.
Judith Del Campo, Caridad Zayas, Belkis Romeu, Reinaldo Acevedo, Elizabeth González

Methods· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice.
Reinaldo Acevedo, Adriana Callicó, Judith del Campo, Elizabeth González, Bárbara Cedré

Methods· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A proteoliposome based formulation administered by the nasal route produces vibriocidal antibodies against El Tor Ogawa Vibrio cholerae O1 in BALB/c mice.
José Luis Pérez, Reinaldo Acevedo, Adriana Callicó, Yovania Fernández, Bárbara Cedré

Vaccine· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivery systems: a vaccine strategy for overcoming mucosal tolerance?
Jamie F S Mann, Reinaldo Acevedo, Judith Del Campo, Oliver Pérez, Valerie A Ferro

Expert Rev Vaccines· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The adjuvant potential of synthetic alkylglycerols.
Reinaldo Acevedo, Danay Gil, Judith del Campo, Gustavo Bracho, Yolanda Valdés

Vaccine· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological evaluation of bacterial derived Cochleate and proteoliposome as mucosal adjuvants.
Judith del Campo, Miriam Lastre, Gustavo Bracho, Tamara Rodríguez, Danay Gil, Reinaldo Acevedo

Vaccine· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteliposome-derived Cochleate as an immunomodulator for nasal vaccine.
Oliver Pérez, Gustavo Bracho, Miriam Lastre, Caridad Zayas, Domingo González, Reinaldo Acevedo

Vaccine· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategy for determination of an efficient Cochleate particle size.
Danay Gil, Gustavo Bracho, Caridad Zayas, Judith del Campo, Reinaldo Acevedo

Vaccine· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scale up of proteoliposome derived Cochleate production.
Caridad Zayas, Gustavo Bracho, Miriam Lastre, Domingo González, Danay Gil, Reinaldo Acevedo

Vaccine· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis